Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases... Show more
VMTHF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 2 cases where VMTHF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on October 31, 2025. You may want to consider a long position or call options on VMTHF as a result. In of 12 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for VMTHF just turned positive on November 06, 2025. Looking at past instances where VMTHF's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator for VMTHF entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.473) is normal, around the industry mean (63.534). P/E Ratio (0.000) is within average values for comparable stocks, (37.086). VMTHF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.687). VMTHF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (2.270) is also within normal values, averaging (79.919).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VMTHF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VMTHF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Industry MedicalNursingServices
A.I.dvisor tells us that VMTHF and AVCRF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VMTHF and AVCRF's prices will move in lockstep.
| Ticker / NAME | Correlation To VMTHF | 1D Price Change % | ||
|---|---|---|---|---|
| VMTHF | 100% | N/A | ||
| AVCRF - VMTHF | 23% Poorly correlated | -4.41% | ||
| LUCD - VMTHF | 4% Poorly correlated | +6.73% | ||
| BJDX - VMTHF | 2% Poorly correlated | -6.36% | ||
| MDXH - VMTHF | 1% Poorly correlated | -7.42% | ||
| BCCOY - VMTHF | 0% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To VMTHF | 1D Price Change % |
|---|---|---|
| VMTHF | 100% | N/A |
| Health Services category (422 stocks) | 0% Poorly correlated | -2.10% |
| Medical/Nursing Services category (215 stocks) | -4% Poorly correlated | -2.32% |